GB2447012B - Composition for combating epistaxis - Google Patents

Composition for combating epistaxis

Info

Publication number
GB2447012B
GB2447012B GB0703377A GB0703377A GB2447012B GB 2447012 B GB2447012 B GB 2447012B GB 0703377 A GB0703377 A GB 0703377A GB 0703377 A GB0703377 A GB 0703377A GB 2447012 B GB2447012 B GB 2447012B
Authority
GB
United Kingdom
Prior art keywords
epistaxis
combating
composition
combating epistaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0703377A
Other languages
English (en)
Other versions
GB0703377D0 (en
GB2447012A (en
Inventor
Bjoern Petruson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacure Health Care AB
Original Assignee
Pharmacure Health Care AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacure Health Care AB filed Critical Pharmacure Health Care AB
Priority to GB0703377A priority Critical patent/GB2447012B/en
Publication of GB0703377D0 publication Critical patent/GB0703377D0/en
Priority to DK08709491.8T priority patent/DK2117502T3/en
Priority to HRP20161626TT priority patent/HRP20161626T1/hr
Priority to CA2678706A priority patent/CA2678706C/en
Priority to CN200880005428.8A priority patent/CN101677940B/zh
Priority to AU2008217608A priority patent/AU2008217608B2/en
Priority to KR1020097019543A priority patent/KR20090130001A/ko
Priority to US12/525,975 priority patent/US9138406B2/en
Priority to ES08709491.8T priority patent/ES2606947T3/es
Priority to PCT/GB2008/000608 priority patent/WO2008102150A2/en
Priority to EP08709491.8A priority patent/EP2117502B1/en
Priority to ZA200905519A priority patent/ZA200905519B/xx
Priority to RU2009134086/15A priority patent/RU2473327C2/ru
Priority to PL08709491T priority patent/PL2117502T3/pl
Priority to JP2009550758A priority patent/JP2010519285A/ja
Priority to PT87094918T priority patent/PT2117502T/pt
Priority to BRPI0807732A priority patent/BRPI0807732B8/pt
Priority to HUE08709491A priority patent/HUE031199T2/en
Publication of GB2447012A publication Critical patent/GB2447012A/en
Priority to IL200277A priority patent/IL200277A0/en
Application granted granted Critical
Publication of GB2447012B publication Critical patent/GB2447012B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0703377A 2007-02-21 2007-02-21 Composition for combating epistaxis Expired - Fee Related GB2447012B (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB0703377A GB2447012B (en) 2007-02-21 2007-02-21 Composition for combating epistaxis
EP08709491.8A EP2117502B1 (en) 2007-02-21 2008-02-21 Composition for combating epistaxis
RU2009134086/15A RU2473327C2 (ru) 2007-02-21 2008-02-21 Композиция для борьбы с эпистаксисом
CA2678706A CA2678706C (en) 2007-02-21 2008-02-21 Composition for combating epistaxis
CN200880005428.8A CN101677940B (zh) 2007-02-21 2008-02-21 一种治疗鼻出血的组合物
AU2008217608A AU2008217608B2 (en) 2007-02-21 2008-02-21 Composition for combating epistaxis
KR1020097019543A KR20090130001A (ko) 2007-02-21 2008-02-21 코피 방지용 조성물
US12/525,975 US9138406B2 (en) 2007-02-21 2008-02-21 Composition for combating epistaxis
ES08709491.8T ES2606947T3 (es) 2007-02-21 2008-02-21 Composición para combatir epistaxis
PCT/GB2008/000608 WO2008102150A2 (en) 2007-02-21 2008-02-21 Composition for combating epistaxis
DK08709491.8T DK2117502T3 (en) 2007-02-21 2008-02-21 COMPOSITION TO FIGHT EPISTAXIS
ZA200905519A ZA200905519B (en) 2007-02-21 2008-02-21 Composition for combating epistaxis
HRP20161626TT HRP20161626T1 (hr) 2007-02-21 2008-02-21 Pripravak protiv epistakse
PL08709491T PL2117502T3 (pl) 2007-02-21 2008-02-21 Kompozycja do zwalczania epistaksji
JP2009550758A JP2010519285A (ja) 2007-02-21 2008-02-21 鼻血に対抗するための組成物
PT87094918T PT2117502T (pt) 2007-02-21 2008-02-21 Composição para combater a epistaxe
BRPI0807732A BRPI0807732B8 (pt) 2007-02-21 2008-02-21 composição em gel, processo para fabricação da composição e uso de uma composição
HUE08709491A HUE031199T2 (en) 2007-02-21 2008-02-21 Preparation for bleeding
IL200277A IL200277A0 (en) 2007-02-21 2009-08-06 Composition for combating epistaxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0703377A GB2447012B (en) 2007-02-21 2007-02-21 Composition for combating epistaxis

Publications (3)

Publication Number Publication Date
GB0703377D0 GB0703377D0 (en) 2007-03-28
GB2447012A GB2447012A (en) 2008-09-03
GB2447012B true GB2447012B (en) 2011-03-16

Family

ID=37909023

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0703377A Expired - Fee Related GB2447012B (en) 2007-02-21 2007-02-21 Composition for combating epistaxis

Country Status (19)

Country Link
US (1) US9138406B2 (enExample)
EP (1) EP2117502B1 (enExample)
JP (1) JP2010519285A (enExample)
KR (1) KR20090130001A (enExample)
CN (1) CN101677940B (enExample)
AU (1) AU2008217608B2 (enExample)
BR (1) BRPI0807732B8 (enExample)
CA (1) CA2678706C (enExample)
DK (1) DK2117502T3 (enExample)
ES (1) ES2606947T3 (enExample)
GB (1) GB2447012B (enExample)
HR (1) HRP20161626T1 (enExample)
HU (1) HUE031199T2 (enExample)
IL (1) IL200277A0 (enExample)
PL (1) PL2117502T3 (enExample)
PT (1) PT2117502T (enExample)
RU (1) RU2473327C2 (enExample)
WO (1) WO2008102150A2 (enExample)
ZA (1) ZA200905519B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9138406B2 (en) 2007-02-21 2015-09-22 Pharmacure Health Care Ab Composition for combating epistaxis
USD993736S1 (en) 2023-05-17 2023-08-01 Line Work Bucket Products, LLC Auger and socket holder

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026030821A1 (en) * 2024-08-07 2026-02-12 Conlin Anne Nasal formulations for non-invasive nasal delivery

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275054A1 (en) * 1987-01-14 1988-07-20 Toko Yakuhin Kogyo Kabushiki Kaisha Ointment base and ointment
WO2001000218A1 (en) * 1999-06-30 2001-01-04 Scott Cordray Nasal spray having dead sea salts
US6365131B1 (en) * 1997-10-31 2002-04-02 J. B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363319A (en) * 1980-06-30 1982-12-14 Applied Medical Devices, Inc. Ready-to-use bandage incorporating a coagulant composition and method of preparing same
AU2793292A (en) * 1991-10-11 1993-05-03 Novo Nordisk A/S Hemostatic composition for local hemostasis
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5928611A (en) * 1995-06-07 1999-07-27 Closure Medical Corporation Impregnated applicator tip
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
RU2156612C1 (ru) * 2000-03-13 2000-09-27 Волков Александр Григорьевич Способ остановки носового кровотечения
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7303759B2 (en) * 2001-06-22 2007-12-04 The United States Of America As Represented By The Secretary Of The Army Compositions and methods for reducing blood and fluid loss from open wounds
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
RU2290937C1 (ru) * 2005-10-03 2007-01-10 Владислав Владимирович Петров Способ остановки носового кровотечения
GB2447012B (en) 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275054A1 (en) * 1987-01-14 1988-07-20 Toko Yakuhin Kogyo Kabushiki Kaisha Ointment base and ointment
US6365131B1 (en) * 1997-10-31 2002-04-02 J. B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic
WO2001000218A1 (en) * 1999-06-30 2001-01-04 Scott Cordray Nasal spray having dead sea salts
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9138406B2 (en) 2007-02-21 2015-09-22 Pharmacure Health Care Ab Composition for combating epistaxis
USD993736S1 (en) 2023-05-17 2023-08-01 Line Work Bucket Products, LLC Auger and socket holder

Also Published As

Publication number Publication date
CN101677940B (zh) 2014-02-19
PT2117502T (pt) 2016-12-13
IL200277A0 (en) 2010-04-29
US20100119472A1 (en) 2010-05-13
HUE031199T2 (en) 2017-07-28
JP2010519285A (ja) 2010-06-03
KR20090130001A (ko) 2009-12-17
ZA200905519B (en) 2010-10-27
CN101677940A (zh) 2010-03-24
RU2009134086A (ru) 2011-03-27
EP2117502B1 (en) 2016-11-09
DK2117502T3 (en) 2017-01-23
CA2678706C (en) 2014-11-18
CA2678706A1 (en) 2008-08-28
ES2606947T3 (es) 2017-03-28
GB0703377D0 (en) 2007-03-28
EP2117502A2 (en) 2009-11-18
BRPI0807732A2 (pt) 2014-06-03
AU2008217608A1 (en) 2008-08-28
RU2473327C2 (ru) 2013-01-27
HRP20161626T1 (hr) 2017-03-10
BRPI0807732B1 (pt) 2020-08-04
PL2117502T3 (pl) 2017-08-31
WO2008102150A2 (en) 2008-08-28
AU2008217608B2 (en) 2013-01-10
GB2447012A (en) 2008-09-03
BRPI0807732B8 (pt) 2021-05-25
WO2008102150A3 (en) 2009-04-30
US9138406B2 (en) 2015-09-22

Similar Documents

Publication Publication Date Title
GB0718777D0 (en) Composition
GB0700534D0 (en) Composition
GB0711683D0 (en) Compositions
GB0717182D0 (en) Composition
GB0722550D0 (en) Composition
GB0714575D0 (en) Composition
GB0710888D0 (en) Composition
SI2154121T1 (sl) Biognojilni sestavek
GB0715068D0 (en) Improved composition
GB0716591D0 (en) Composition
GB0714569D0 (en) Composition
GB0705885D0 (en) Composition
GB0703719D0 (en) Composition
GB0706343D0 (en) Composition
GB0702446D0 (en) Composition
IL200277A0 (en) Composition for combating epistaxis
GB0707972D0 (en) Composition
GB0706739D0 (en) Composition
GB0704651D0 (en) Composition
GB0704659D0 (en) Composition
GB0721430D0 (en) Composition
GB0713976D0 (en) Composition
GB0710559D0 (en) Composition
GB0703087D0 (en) Composition
GB0715705D0 (en) Composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20240221